Achelios Therapeutics LLC is categorized under Commercial Medical Research in Chapel Hill, NC and active since 2012.
Achelios Therapeutics LLC was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Crist Frangakis at the company’s single location by writing to 6340 Quadrangle Drive # 120, Chapel Hill, North Carolina NC 27517 or by phoning (919) 354-6233. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Achelios Therapeutics LLC |
| Contact Person: | Crist Frangakis |
| Address: | 6340 Quadrangle Drive # 120, Chapel Hill, North Carolina 27517 |
| Phone Number: | (919) 354-6233 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Achelios Therapeutics LLC was started in 2012 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Crist Frangakis for inquiries that concern Achelios Therapeutics LLC by calling the company number (919) 354-6233, as your correspondence is most welcome. Additionally, the physical location of the single location of Achelios Therapeutics LLC can be found at the coordinates 35.91289,-78.979001 as well as the street address 6340 Quadrangle Drive # 120 in Chapel Hill, North Carolina 27517.
For its online presence, you may visit Achelios Therapeutics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.